Clinical Trial Update: First Study to Evaluate the Capacity of Maraviroc Drug to Protect Against HIV Infection in Samples of Rectal Mucosa From Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study evaluated whether maraviroc could protect against HIV infection in rectal mucosa samples from healthy volunteers. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Selzentry (Maraviroc)

Snippet

Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | Conditions: HIV | Phase 1 | Status: COMPLETED